5814-38-0

Basic information

• Product Name: ETHYL 4-(4-CHLOROPHENYL)-2,4-DIOXOBUTANOATE
• Synonyms: benzenebutanoic acid, 4-chloro-alpha,gamma-dioxo-, ethyl e;Ethyl 4-(4-chlorophenyl)-2,4-dioxobutyrate;Benzenebutanoic acid, 4-chloro-.alpha.,.gaMMa.-dioxo-, ethyl ester;Ethyl 4-chloro-a,g-dioxo-benzenebutanoate;2-Oxo-3-[3-chlorobenzoyl]propanoic acid, ethyl ester;4-(4-chlorophenyl)-2,4-diketo-butyric acid ethyl ester;4-(4-chlorophenyl)-2,4-dioxobutanoic acid ethyl ester;Benzenebutanoic acid, 4-chloro-a,g-dioxo-, ethyl ester
• CAS NO: 5814-38-0
• Molecular Formula: C₁₂H₁₁ClO₄
• Molecular Weight: 254.67
• Mol File: 5814-38-0.mol

Chemical Properties

• Melting Point: 61-62.5 °C (decomp)
• Boiling Point: 392.8°Cat760mmHg
• Flash Point: 164.7°C
• Appearance: /
• Density: 1.276g/cm³
• Vapor Pressure: 2.23E-06mmHg at 25°C
• Refractive Index: 1.528
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 5.73±0.25(Predicted)
• CAS DataBase Reference: ETHYL 4-(4-CHLOROPHENYL)-2,4-DIOXOBUTANOATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL 4-(4-CHLOROPHENYL)-2,4-DIOXOBUTANOATE(5814-38-0)
• EPA Substance Registry System: ETHYL 4-(4-CHLOROPHENYL)-2,4-DIOXOBUTANOATE(5814-38-0)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 5814-38-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
ETHYL 4-(4-CHLOROPHENYL)-2,4-DIOXOBUTANOATE is used as a key intermediate in the synthesis of various pharmaceuticals for its specific chemical and biological properties that contribute to the development of new drugs.
Used in Agrochemical Industry:
In the agrochemical sector, ETHYL 4-(4-CHLOROPHENYL)-2,4-DIOXOBUTANOATE serves as an essential component in the production of agrochemicals, leveraging its unique structure to enhance the effectiveness of these compounds in agricultural applications.
Used in Organic Synthesis:
ETHYL 4-(4-CHLOROPHENYL)-2,4-DIOXOBUTANOATE is utilized as a versatile intermediate in organic synthesis, allowing for the creation of a wide range of organic compounds due to its reactive functional groups and molecular structure.

InChI:InChI=1/C12H11ClO4/c1-2-17-12(16)11(15)7-10(14)8-3-5-9(13)6-4-8/h3-6H,2,7H2,1H3

Upstream product

• 99-91-2 para-chloroacetophenone 
• 95-92-1 oxalic acid diethyl ester 
• 98-86-2 acetophenone 

Downstream Products

• 70372-52-0 (Z)-3-(2-(4-chlorophenyl)-2-oxoethylidene)-3,4-dihydro-2H-benzo[b][1,4]oxazin-2-one 
• 83715-76-8 6-[2-(4-Chloro-phenyl)-2-oxo-ethyl]-2-methyl-3-thioxo-3,4-dihydro-2H-[1,2,4]triazin-5-one 
• 155537-03-4 2-(4-chlorophenyl)-4-ethoxycarbonyl-5-oxo-5,6,7,8-tetrahydroquinoline 
• 1082746-75-5 ethyl 1,5-bis(4-chlorophenyl)-1H-pyrazole-3-carboxylate 
• 1082746-74-4 ethyl 5-(4-chlorophenyl)-1-phenyl-1H-pyrazole-3-carboxylate 
• 501426-53-5 1-(2,4-dichlorophenyl)-5-(4-chlorophenyl)-1H-pyrazole-3-carboxylic acid ethyl ester 
• 70015-76-8 4-amino-3-phenyl-1H-pyrazole-5-carboxylic acid ethyl ester 
• 299921-97-4 C₁₆H₁₁ClN₄O₂ 
• 1224879-13-3 3-(4-chlorophenyl)-4-phenylazo-1H-pyrazole-5-carboxylic acid ethyl ester 
• 70015-80-4 3-phenyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one 
• 1224879-19-9 C₁₁H₇ClN₄O 
• 91857-59-9 ethyl 4-amino-5-(4-chlorophenyl)-2H-pyrazole-3-carboxylate 
• 1224879-08-6 C₁₈H₁₅ClN₂O₄ 
• 370096-67-6 5-(4-chlorophenyl)-1H-pyrazole-3-carbohydrazide 

Relevant articles and documents

Synthesis and Biological Screening of Novel 5-(5-Aryl-1-phenyl-1H-pyrazol-3-yl)-3-aryl-1,2,4-oxadiazole Derivatives

A new series of 5-(5-aryl-1-phenyl-1H-pyrazol-3-yl)-3-aryl-1,2,4-oxadiazole (6a-o) have been synthesized by a cyclocondensation reaction of ethyl 5-(4-chlorophenyl)-1-phenyl-1H-pyrazole-3-carboxylate (3a-c) with aryl imidoxime (5a-e). The newly synthesize

Lewis acid-promoted synthesis of highly substituted pyrrole-fused benzoxazinones and quinoxalinones

A synthesis of a series of novel fused tricyclic heterocyclic compounds has been achieved in one-pot reaction set up starting from (E)-3-(2-oxo-2-phenylethylidene)indolin-2-one and 1,4-benzoxazinone/quinoxalinone derivatives promoted by tin(IV) chloride.

Novel N-benzylpiperidine derivatives of 5-arylisoxazole-3-carboxamides as anti-Alzheimer's agents

The complex pathophysiology of Alzheimer's disease (AD) has prompted researchers to develop multitarget-directed molecules to find an effective therapy against the disease. In this context, a novel series of N-(1-benzylpiperidin-4-yl)-5-arylisoxazole-3-ca

Structure–activity relationship studies of 3-substituted pyrazoles as novel allosteric inhibitors of MALT1 protease

We report the discovery of a novel series of 1,5-bisphenylpyrazoles as potent MALT1 inhibitors. Structure–activity relationship exploration of a hit compound led to a potent MALT1 inhibitor. Compound 33 showed strong activity against MALT1 (IC50/sub

Ring-chain transformation of 4-aroyl-5-phenylamino-2,3-dihydrothiophene-2,3-diones: Facile and efficient synthesis of novel pyrrolo[2,3-c]pyrazol-3(2H)-ones and 1,2-dihydro-5H,6H-pyridazine-5,6-diones

Seven, novel pyrrolo[2,3-c]pyrazol-3(2H)-one and 1,2-dihydro-5H,6H-pyridazine-5,6-dione chromophores were synthesized by the reaction of 4-aroyl-5-phenylamino-2,3-dihydrothiophene-2,3-diones with cyanoacetohydrazide and arylhydrazines such as phenylhydrazine and 4-nitrophenylhydrazine. These derivatives were characterized by elemental analysis, IR, UV-Visible, 1H, 13C NMR and mass spectroscopy. Spectral characteristics of the compounds were studied in four organic solvents of differing polarity.

Design and Synthesis of Novel Arylisoxazole-Chromenone Carboxamides: Investigation of Biological Activities Associated with Alzheimer's Disease

A novel series of hybrid arylisoxazole-chromenone carboxamides were designed, synthesized, and evaluated for their cholinesterase (ChE) inhibitory activity based on the modified Ellman's method. Among synthesized compounds, 5-(3-nitrophenyl)-N-{4-[(2-oxo-

Green and efficient synthesis of new pyrido[2,3-d]pyrimidine derivatives using Pd/SBA-15 as a nanocatalyst

N-Fused heterocycles have received significant attention over the years as valuable compounds due to their biological and pharmaceutical activities. Heterogeneous catalysts such as periodic mesoporous materials have played an important role in the synthes

Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors

Monoacylglycerol lipase (MAGL) is a serine hydrolase that plays an important role in the degradation of the endocannabinoid neurotransmitter 2-arachidonoylglycerol, which is implicated in many physiological processes. Beyond the possible utilization of MA

Synthetic method of OLED material intermediate benzoyl pyrimidine compound

The invention discloses a synthetic method of an OLED material intermediate benzoyl pyrimidine compound. The synthetic method comprises the following steps: mixing alkali, a solvent I as well as substituent acetophenone and oxalic acid diester which are u

Development of novel bis-pyrazole derivatives as antitumor agents with potent apoptosis induction effects and DNA damage

A series of bis-pyrazole derivatives were designed and synthesized, and their antitumor effects in vitro and in vivo were investigated. Several compounds displayed good antiproliferative activity with IC50 values in low-micromolar range against three human cancer cell lines in vitro, superior to 5-FU. The most potent compound 10M selectively inhibited human hepatocellular carcinoma cells but not non-tumor liver cell proliferation in vitro, and significantly triggered SMMC-7721 cell apoptosis by cleavage of both PARP and caspase-3 in a concentration-dependent manner. Further study revealed that the potent activity in the cell growth inhibition and apoptosis induction effects of 10M were related to DNA damage and activation of the p53 signaling pathway. Moreover, 10M showed low acute toxicity to mice and significant growth inhibition of the hepatoma tumor in vivo.